Recce Pharmaceuticals (ASX:RCE) accelerates commercialisation with positive Phase II results.
Resmed has reported it received an exemption from the current US Administration, meaning it can keep sending its products from Australia.
24 Apr 2025 12:48 (AEST)
ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.
26 Apr 2024 13:45 (AEST)
Cloud-connected medical devices creator ResMed (ASX:RMD) has published its results for the first quarter of the 2024 fiscal year.
27 Oct 2023 12:02 (AEDT)
ResMed (ASX:RMD) has announced its financial results for Q4 FY23, highlighting RMD revenue increased by 23 per cent to $1.1 billion.
04 Aug 2023 11:26 (AEST)
ResMed (ASX:RMD) CEO Michael Farrell takes over the role of Chairman from his father, Peter Farrell, as company profit soars.
27 Jan 2023 13:48 (AEDT)
This week on Money and Investing, Mitch Olarenshaw and I break down the strategy behind Cash Flow on Demand @ a proven system for generating consistent income from the sharemarket with lower risk.1. The cash flow on demand strategyThis income strategy has been our flagship approach at Australian ...